Brimonidine Tartrate Ophthalmic Solution 0.2%
Overview
Brimonidine Tartrate Ophthalmic Solution 0.2% is an alpha-2 adrenergic receptor agonist used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. By reducing IOP, it helps prevent damage to the optic nerve and loss of vision.
Indications
- Open-Angle Glaucoma: Used to reduce elevated IOP in this chronic condition.
- Ocular Hypertension: Helps manage high pressure inside the eye, which can lead to glaucoma.
Dosage and Administration
- Recommended Dosage: One drop in the affected eye(s) three times daily, approximately 8 hours apart.
- Instructions: To avoid contamination, do not let the dropper tip touch the eye or any other surface. Wait at least 15 minutes before reinserting contact lenses.
Side Effects
Common side effects include:
- Dry mouth
- Eye redness and irritation
- Drowsiness
- Blurred vision
- Headache
Serious side effects may include allergic reactions, cardiovascular issues like bradycardia or hypotension, and signs of eye infection.
Precautions
- Contraindications: Not suitable for infants under 2 years and individuals with known hypersensitivity to the drug.
- Use with Caution: In patients with severe cardiovascular disease, depression, or those prone to vascular insufficiency.
Storage
Store at room temperature (20° to 25°C) and protect from light. Do not freeze.
Always follow your healthcare provider's instructions when using Brimonidine Tartrate Ophthalmic Solution and report any adverse reactions. This medication should be used under medical supervision, especially if combined with other ophthalmic treatments.